| Contributors: |
The authors wish to express their appreciation and thanks to GBUZ TO Regional Clinical Hospital No. 2, GAUZ TO Tumen City Outpatient Clinic No. 3, GAUZ TO City Outpatient Clinic No. 12, GAUZ TO City Outpatient Clinic No. 17, which were involved in the implementation of the pilot project in the city of Tumen, as well as to the following endocrinologists participated directly in remote monitoring of self-monitoring of blood glucose (SMBG): Irina V. Kurtekova, Lyudmila A. Kirshanova, Alena N. Valenyuk, Svetlana S. Salo, Margarita I. Patrusheva, Larisa A. Pimshina, Yulia P. Kogut, Olga M. Moisieva, Anastasia A. Gorbunova. The authors are grateful for the technical support of OOO ELTA Company’s project.; Авторы выражают благодарность ГБУЗ ТО «Областная клиническая больница №2», ГАУЗ ТО «Городская поликлиника №3», ГАУЗ ТО «Городская поликлиника №12», ГАУЗ ТО «Городская поликлиника №17», вовлеченным в реализацию пилотного проекта в г. Тюмени; врачам-эндокринологам, принимающим непосредственное участие в дистанционном мониторинге СКГ: Куртековой Ирине Владимировне, Киршановой Людмиле Александровне, Валенюк Алене Николаевне, Сало Светлане Сергеевне, Патрушевой Маргарите Ильиничне, Пимшиной Ларисе Анатольевне, Когут Юлии Павловне, Мойсиевой Ольге Михайловне, Горбуновой Анастасии Александровне. Авторы признательны за техническую поддержку проекта ООО «Компания «ЭЛТА». |
| Description: |
Introduction. Despite the availability of modern drugs and self-monitoring blood glucose (SMBG) tools, as well as therapeutic training for patients with diabetes mellitus (DM), the percentage of non-achievement of glycated hemoglobin (HbA1c) targets remains high, that necessitates new approaches to treatment developing.Aim. Evaluate the possibilities of SMBG remote monitoring in the treatment of type 2 DM in order to improve the effectiveness of outpatient care.Materials and methods. Patients with type 2 DM and HbA1c from 8.0 to 12.0% were divided into groups on tablet therapy (DM2T) and intensified insulin therapy (DM2I). Also, by the type of SMBG the main group (DM2T 86 people, DM2I 72 people) and control groups (DM2T 20 people, DM2I 20 people) were formed. In the main group patients performed SMBG using glucometers with the possibility of remote monitoring by an endocrinologist, control group continued traditional SMBG. The follow-up period was 6 months, we assessed the dynamics of HbA1c, the frequency of SMBG, quality of life using the SF-36 questionnaire, and the attitude of patients to remote monitoring of SMBG. Statistical analysis was performed using StatTech v. 4.6.3 (developer Stattech LLC, Russia), SPSS Version 26.0 (IBM, USA).Results. HbA1c decreased in the main group by 0.9% after 6 months among the DM2T patients (p < 0.001) and by 1,5% in the DM2I group (p < 0.001). In the control group DM2T, the decrease in HbA1c was insignificant (p = 0.607), and in the group DM2I a negative trend was observed (p = 0.007). The quality of life also improved due to indicators of mental health in the main group (p < 0.05). The majority of patients in the main group DM2I and DM2T noted the positive effect of remote monitoring of SMBG (97.2% and 100%, respectively).Conclusion. Remote monitoring of SMBG may become a successful tool in improving the effectiveness of outpatient care for patients with type 2 DM. ; Введение. Несмотря на современные лекарственные препараты, доступность средств самоконтроля гликемии ... |
| Relation: |
https://www.med-sovet.pro/jour/article/view/9077/7886; Дедов ИИ, Шестакова МВ, Викулова ОК, Железнякова АВ, Исаков МА, Сазонова ДВ, Мокрышева НГ. Сахарный диабет в Российской Федерации: динамика эпидемиологических показателей по данным Федерального регистра сахарного диабета за период 2010–2022 гг. Сахарный диабет. 2023;26(2):104–123. https://doi.org/10.14341/DM13035.; Смирнов СД, Корнилова ТВ, Суркова ЕВ, Двойнишникова ОМ, Анциферов МБ. Психологические особенности больных сахарным диабетом типа 2; проблемы терапевтического обучения. Проблемы эндокринологии. 2001;47(6):27–34. https://doi.org/10.14341/probl11736.; Kilvert A, Wilmot EG, Davies M, Fox C. Virtual consultations: are we missing anything? Pract Diab. 2020;37(4):143–146. https://doi.org/10.1002/pdi.2288.; Car J, Koh GC, Foong PS, Wang CJ. Video consultations in primary and specialist care during the covid-19 pandemic and beyond. BMJ. 2020;371:m3945. https://doi.org/10.1136/bmj.m3945диабет; Flumignan CDQ, Rocha APD, Pinto ACPN, Milby KMM, Batista MR, Atallah ÁN, Saconato H. What do Cochrane systematic reviews say about telemedicine for healthcare? Sao Paulo Med J. 2019;137(2):184–192. https://doi.org/10.1590/1516-3180.0177240419.; Johnson EL, Miller E. Remote Patient Monitoring in Diabetes: How to Acquire, Manage, and Use All of the Data. Diabetes Spectr. 2022;35(1):43–56. https://doi.org/10.2337/dsi21-0015.; Лаптев ДН, Филиппов ЮИ, Карпушкина АВ, Петеркова ВА. Применение телемедицины у больных сахарным диабетом. М.: Литтерра; 2018. 64 с.; Wang K, Zou W, Lai Y, Hao C, Liu N, Ling X et al. Accessibility, Cost, and Quality of an Online Regular Follow-Up Visit Service at an Internet Hospital in China: Mixed Methods Study. J Med Internet Res. 2024;26:e54902. https://doi.org/10.2196/54902.; Joubert M, Benhamou PY, Schaepelynck P, Hanaire H, Catargi B, Farret A et al. Remote Monitoring of Diabetes: A Cloud-Connected Digital System for Individuals With Diabetes and Their Health Care Providers. J Diabetes Sci Technol. 2019;13(6):1161–1168. https://doi.org/10.1177/1932296819834054.; Grady M, Cameron H, Holt E. Sustained Improvements in Readings inRange Using an Advanced Bluetooth® Connected Blood Glucose Meter and a Mobile Diabetes App: Real-World Evidence from more than 55,000 People with Diabetes. Diabetes Ther. 2023;14(6):1023–1035. https://doi.org/10.1007/s13300-023-01415-3.; Grady M, Cameron H, Bhatiker A, Holt E, Schnell O. Real-World Evidence of Improved Glycemic Control in People with Diabetes Using a Bluetooth-Connected Blood Glucose Meter with a Mobile Diabetes Management App. Diabetes Technol Ther. 2022;24(10):770–778. https://doi.org/10.1089/dia.2022.0134.; Alanzi T, Rehman SU, Khan MA, Istepanian RSH. The evolution and mapping trends of mobile health (m-Health): a bibliometric analysis (1997–2023). Mhealth. 2024;10:23. https://doi.org/10.21037/mhealth-23-20.; Istepanian RH, Woodward B, Gorilas E, Balos PA. Design of mobile telemedicine systems using GSM and IS-54 cellular telephone standards. J Telemed Telecare. 1998;4(Suppl. 1):80–82. https://doi.org/10.1258/1357633981931579.; S AK, Bali S, Pakhare AP, Khadanga S. Feasibility of Self-Management of Hypertension and Diabetes Using Patient-Generated Health Data Through M-health in Central India. Cureus. 2024;16(2):e55060. https://doi.org/10.1258/1357633981931579.; Hou C, Carter B, Hewitt J, Francisa T, Mayor S. Do Mobile Phone Applications Improve Glycemic Control (HbA1c) in the Self-management of Diabetes? A Systematic Review, Meta-analysis, and GRADE of 14 Randomized Trials. Diabetes Care. 2016;39(11):2089–2095. https://doi.org/10.2337/dc16-0346.; Дедов ИИ, Шестакова МВ, Майоров АЮ, Шамхалова МШ, Сухарева ОЮ, Галстян ГР и др. Сахарный диабет 2 типа у взрослых: клинические рекомендации. 2022. Режим доступа: https://clck.ru/3M7cL9.; Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey. Manual and interpretation guide. The Health Institute, New England Medical Center. Boston, Mass; 1993. Available at: https://www.researchgate.net/publication/247503121_SF36_Health_Survey_Manual_and_Interpretation_Guide.; Hou C, Xu Q, Diao S, Hewitt J, Li J, Carter B. Mobile phone applications and self-management of diabetes: A systematic review with meta-analysis, meta-regression of 21 randomized trials and GRADE. Diabetes Obes Metab. 2018;20(8):2009–2013. https://doi.org/10.1111/dom.13307.; Tang Z, Zhao L, Li J, Yang Y, Liu F, Li H et al. Prognostic effectiveness of interactive vs. non-interactive mobile app interventions in type 2 diabetes: a systematic review and meta-analysis. Arch Public Health. 2024;82(1):221. https://doi.org/10.1186/s13690-024-01450-x.; Ruissen MM, Torres-Peña JD, Uitbeijerse BS, Arenas de Larriva AP, Huisman SD, Namli T et al. POWER2DM Consortium. Clinical impact of an integrated e-health system for diabetes self-management support and shared decision making (POWER2DM): a randomised controlled trial. Diabetologia. 2023;66(12):2213–2225. https://doi.org/10.1007/s00125-023-06006-2.; Sun X, Zhou X, Li S, Ji L. Association between frequency of self-monitoring of blood glucose and glycemic control in patients with type 2 diabetes. Diabetes Res Clin Pract. 2024;209:111027. https://doi.org/10.1016/j.diabres.2023.111027.; Zou Y, Zhao S, Li G, Zhang C. The Efficacy and Frequency of Self-monitoring of Blood Glucose in Non-insulin-Treated T2D Patients: a Systematic Review and Meta-analysis. J Gen Intern Med. 2023;38(3):755–764. https://doi.org/10.1007/s11606-022-07864-z.; Sabahi A, Jalali S, Ameri F, Garavand A, Negahban A. The effect of using mobile health on self-management of type 2 diabetic patients: A systematic review in Iran. J Educ Health Promot. 2023;12:358. https://doi.org/10.4103/jehp.jehp_910_22.; Kerr D, Ahn D, Waki K, Wang J, Breznen B, Klonoff DC. Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis. J Med Internet Res. 2024;26:e55757. https://doi.org/10.2196/55757.; Allegrante JP, Wells MT, Peterson JC. Interventions to Support Behavioral Self-Management of Chronic Diseases. Annu Rev Public Health. 2019;40:127–146. https://doi.org/10.1146/annurev-publhealth-040218-044008.; Sneha S, Thalla S, Rischie I, Shahriar H. Health Internet Technology for Chronic Conditions: Review of Diabetes Management Apps. JMIR Diabetes. 2021;6(3):e17431. https://doi.org/10.2196/17431.; Lam K, Lu AD, Shi Y, Covinsky KE. Assessing Telemedicine Unreadiness Among Older Adults in the United States During the COVID-19 Pandemic. JAMA Intern Med. 2020;180(10):1389–1391. https://doi.org/10.1001/jamainternmed.2020.2671.; Stevens S, Gallagher S, Andrews T, Ashall-Payne L, Humphreys L, Leigh S. The effectiveness of digital health technologies for patients with diabetes mellitus: A systematic review. Front Clin Diabetes Healthc. 2022;3:936752. https://doi.org/10.3389/fcdhc.2022.936752.; Doyle-Delgado K, Chamberlain JJ. Use of Diabetes-Related Applications and Digital Health Tools by People With Diabetes and Their Health Care Providers. Clin Diabetes. 2020;38(5):449–461. https://doi.org/10.2337/cd20-0046.; Oikonomidi T, Ravaud P, Cosson E, Montori V, Tran VT. Evaluation of Patient Willingness to Adopt Remote Digital Monitoring for Diabetes Management. JAMA Netw Open. 2021;4(1):e2033115. https://doi.org/10.1001/jamanetworkopen.2020.33115.; Lee SWH, Chan CKY, Chua SS, Chaiyakunapruk N. Comparative effectiveness of telemedicine strategies on type 2 diabetes management: A systematic review and network meta-analysis. Sci Rep. 2017;7(1):12680. https://doi.org/10.1038/s41598-017-12987-z. |